300 related articles for article (PubMed ID: 19235913)
1. Association between genetic variants in myosin IXB and Crohn's disease.
Cooney R; Cummings JR; Pathan S; Beckly J; Geremia A; Hancock L; Guo C; Morris A; Jewell DP
Inflamm Bowel Dis; 2009 Jul; 15(7):1014-21. PubMed ID: 19235913
[TBL] [Abstract][Full Text] [Related]
2. Contributions of IBD5, IL23R, ATG16L1, and NOD2 to Crohn's disease risk in a population-based case-control study: evidence of gene-gene interactions.
Okazaki T; Wang MH; Rawsthorne P; Sargent M; Datta LW; Shugart YY; Bernstein CN; Brant SR
Inflamm Bowel Dis; 2008 Nov; 14(11):1528-41. PubMed ID: 18521914
[TBL] [Abstract][Full Text] [Related]
3. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
4. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene.
Cummings JR; Cooney R; Pathan S; Anderson CA; Barrett JC; Beckly J; Geremia A; Hancock L; Guo C; Ahmad T; Cardon LR; Jewell DP
Inflamm Bowel Dis; 2007 Aug; 13(8):941-6. PubMed ID: 17455206
[TBL] [Abstract][Full Text] [Related]
6. Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: a study in Crohn's disease.
Prager M; Durmus T; Büttner J; Molnar T; de Jong DJ; Drenth JP; Baumgart DC; Sturm A; Farkas K; Witt H; Büning C
Scand J Gastroenterol; 2014 Oct; 49(10):1191-200. PubMed ID: 25098938
[TBL] [Abstract][Full Text] [Related]
7. Replication of genetic variation in the MYO9B gene in Crohn's disease.
Wolters VM; Xu W; Zhao X; Walters TD; Griffiths AM; Silverberg MS; Muise AM
Hum Immunol; 2011 Jul; 72(7):592-7. PubMed ID: 21515326
[TBL] [Abstract][Full Text] [Related]
8. Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
Waller S; Tremelling M; Bredin F; Godfrey L; Howson J; Parkes M
Gut; 2006 Jun; 55(6):809-14. PubMed ID: 16361305
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype.
Cummings JR; Ahmad T; Geremia A; Beckly J; Cooney R; Hancock L; Pathan S; Guo C; Cardon LR; Jewell DP
Inflamm Bowel Dis; 2007 Sep; 13(9):1063-8. PubMed ID: 17508420
[TBL] [Abstract][Full Text] [Related]
10. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants.
Glas J; Seiderer J; Wetzke M; Konrad A; Török HP; Schmechel S; Tonenchi L; Grassl C; Dambacher J; Pfennig S; Maier K; Griga T; Klein W; Epplen JT; Schiemann U; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Müller-Myhsok B; Folwaczny M; Mussack T; Brand S
PLoS One; 2007 Sep; 2(9):e819. PubMed ID: 17786191
[TBL] [Abstract][Full Text] [Related]
11. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
[TBL] [Abstract][Full Text] [Related]
12. Runt-related transcription factor 3 is associated with ulcerative colitis and shows epistasis with solute carrier family 22, members 4 and 5.
Weersma RK; Zhou L; Nolte IM; van der Steege G; van Dullemen HM; Oosterom E; Bok L; Peppelenbosch MP; Faber KN; Kleibeuker JH; Dijkstra G
Inflamm Bowel Dis; 2008 Dec; 14(12):1615-22. PubMed ID: 18668679
[TBL] [Abstract][Full Text] [Related]
13. Variants at the 3p21 locus influence susceptibility and phenotype both in adults and early-onset patients with inflammatory bowel disease.
Latiano A; Palmieri O; Corritore G; Valvano MR; Bossa F; Cucchiara S; Castro M; Riegler G; De Venuto D; D'Incà R; Andriulli A; Annese V
Inflamm Bowel Dis; 2010 Jul; 16(7):1108-17. PubMed ID: 20024904
[TBL] [Abstract][Full Text] [Related]
14. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
15. Two-stage candidate gene study of chromosome 3p demonstrates an association between nonsynonymous variants in the MST1R gene and Crohn's disease.
Beckly JB; Hancock L; Geremia A; Cummings JR; Morris A; Cooney R; Pathan S; Guo C; Jewell DP
Inflamm Bowel Dis; 2008 Apr; 14(4):500-7. PubMed ID: 18200509
[TBL] [Abstract][Full Text] [Related]
16. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.
Weersma RK; Stokkers PC; van Bodegraven AA; van Hogezand RA; Verspaget HW; de Jong DJ; van der Woude CJ; Oldenburg B; Linskens RK; Festen EA; van der Steege G; Hommes DW; Crusius JB; Wijmenga C; Nolte IM; Dijkstra G;
Gut; 2009 Mar; 58(3):388-95. PubMed ID: 18824555
[TBL] [Abstract][Full Text] [Related]
17. Common variants in NOD2 and IL23R are not associated with inflammatory bowel disease in Indians.
Mahurkar S; Banerjee R; Rani VS; Thakur N; Rao GV; Reddy DN; Chandak GR
J Gastroenterol Hepatol; 2011 Apr; 26(4):694-9. PubMed ID: 21155887
[TBL] [Abstract][Full Text] [Related]
18. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
Tremelling M; Cummings F; Fisher SA; Mansfield J; Gwilliam R; Keniry A; Nimmo ER; Drummond H; Onnie CM; Prescott NJ; Sanderson J; Bredin F; Berzuini C; Forbes A; Lewis CM; Cardon L; Deloukas P; Jewell D; Mathew CG; Parkes M; Satsangi J
Gastroenterology; 2007 May; 132(5):1657-64. PubMed ID: 17484863
[TBL] [Abstract][Full Text] [Related]
19. IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab.
Urcelay E; Mendoza JL; Martinez A; Fernandez L; Taxonera C; Diaz-Rubio M; de la Concha EG
World J Gastroenterol; 2005 Feb; 11(8):1187-92. PubMed ID: 15754402
[TBL] [Abstract][Full Text] [Related]
20. Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population.
Lappalainen M; Halme L; Turunen U; Saavalainen P; Einarsdottir E; Färkkilä M; Kontula K; Paavola-Sakki P
Inflamm Bowel Dis; 2008 Aug; 14(8):1118-24. PubMed ID: 18338763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
